Cochrane Abstracts
Antioxidant supplementation for lung disease in cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antioxidant Supplementation for Lung Disease in Cystic Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438442/all/Antioxidant_supplementation_for_lung_disease_in_cystic_fibrosis.
Antioxidant supplementation for lung disease in cystic fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438442/all/Antioxidant_supplementation_for_lung_disease_in_cystic_fibrosis. Accessed November 23, 2024.
Antioxidant supplementation for lung disease in cystic fibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438442/all/Antioxidant_supplementation_for_lung_disease_in_cystic_fibrosis
Antioxidant Supplementation for Lung Disease in Cystic Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438442/all/Antioxidant_supplementation_for_lung_disease_in_cystic_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antioxidant supplementation for lung disease in cystic fibrosis
ID - 438442
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438442/all/Antioxidant_supplementation_for_lung_disease_in_cystic_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
